Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Nicholas

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
International Journal of Molecular Sciences|November 6, 2020
Intrathecal Inflammation in Progressive Multiple SclerosisSalvatore Monaco, Richard Nicholas, Richard Reynolds, et al.
Seizure|August 3, 2025
Retinal thinning in epilepsy: A meta-analysisThomas Chontos, Richard Nicholas, M Francesca Cordeiro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 1, 2021
Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis RegisterAfagh Garjani, Rodden M Middleton, Richard Nicholas, et al.
The Journal of Knee Surgery|November 19, 2018
Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment OptionsCorey Montgomery, Cory Couch, Cynthia L Emory, et al.
Lancet (London, England)|January 22, 2013
Tuberculosis in London: not unexpected - Authors' replyRichard Nicholas, Dima Dahdaleh, Daniel M Altmann, et al.
Journal of Medical Economics|June 22, 2017
Costs and effectiveness of fingolimod versus alemtuzumab in the treatment of highly active relapsing-remitting multiple sclerosis in the UK: re-treatment, discount, and disutilityStephen M Montgomery, Jeanette Kusel, Richard Nicholas, et al.
JRSM Open|October 8, 2014
Sequential strokes in a hyperacute stroke unitJeban Ganesalingam, Sandeep Buddha, Anoma L Carlton-Jones, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial designRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2012
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: a systematic review and meta-analysisRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosisRichard Nicholas, Roberta Magliozzi, Graham Campbell, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
International Journal of Molecular Sciences|November 6, 2020
Intrathecal Inflammation in Progressive Multiple SclerosisSalvatore Monaco, Richard Nicholas, Richard Reynolds, et al.
Seizure|August 3, 2025
Retinal thinning in epilepsy: A meta-analysisThomas Chontos, Richard Nicholas, M Francesca Cordeiro, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 1, 2021
Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis RegisterAfagh Garjani, Rodden M Middleton, Richard Nicholas, et al.
The Journal of Knee Surgery|November 19, 2018
Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment OptionsCorey Montgomery, Cory Couch, Cynthia L Emory, et al.
Lancet (London, England)|January 22, 2013
Tuberculosis in London: not unexpected - Authors' replyRichard Nicholas, Dima Dahdaleh, Daniel M Altmann, et al.
Journal of Medical Economics|June 22, 2017
Costs and effectiveness of fingolimod versus alemtuzumab in the treatment of highly active relapsing-remitting multiple sclerosis in the UK: re-treatment, discount, and disutilityStephen M Montgomery, Jeanette Kusel, Richard Nicholas, et al.
JRSM Open|October 8, 2014
Sequential strokes in a hyperacute stroke unitJeban Ganesalingam, Sandeep Buddha, Anoma L Carlton-Jones, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial designRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2012
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: a systematic review and meta-analysisRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2015
Temporal lobe cortical pathology and inhibitory GABA interneuron cell loss are associated with seizures in multiple sclerosisRichard Nicholas, Roberta Magliozzi, Graham Campbell, et al.
Pageof 17